B

Berndt, Ernst R. and Dubois, Pierre (2012) Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010. TSE Working Paper, n. 12-283

Berndt, Ernst R. and Dubois, Pierre (2016) Impacts of Patent Expiry of Pharmaceutical Treatments in Eight OECD Countries, 2004-2010. International Journal of the Economics of Business, vol. 23 (n° 2). pp. 125-147.

D

Dubois, Pierre, De Mouzon, Olivier, Scott Morton, Fiona and Seabright, Paul (2011) Market Size and Pharmaceutical Innovation. TSE Working Paper, n. 11-232

Dubois, Pierre, Majewska, Gosia and Reig, Valentina (2023) Drug shortages: empirical evidence from France. TSE Working Paper, n. 23-1417, Toulouse

Dubois, Pierre, Mouzon, Olivier de, Scott Morton, Fiona and Seabright, Paul (2015) Market Size and Pharmaceutical Innovation. RAND Journal of Economics, vol. 46 (n° 4). pp. 844-871.

K

Kyle, Margaret and McGahan, Anita M. (2012) Pharmaceutical Investments Before and After TRIPS. Review of Economics and Statistics, 94 (4). pp. 1157-1172.

T

Tunçel, Tuba (2024) Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France. The Review Of Economic Studies.